Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-15-020147
Filing Date
2015-03-16
Accepted
2015-03-16 17:24:48
Documents
17
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a15-1897_110k.htm 10-K 1564514
2 EX-10.3 a15-1897_1ex10d3.htm EX-10.3 102087
3 EX-10.4 a15-1897_1ex10d4.htm EX-10.4 96375
4 EX-10.9 a15-1897_1ex10d9.htm EX-10.9 82173
5 EX-21 a15-1897_1ex21.htm EX-21 1006
6 EX-23 a15-1897_1ex23.htm EX-23 3799
7 EX-31.1 a15-1897_1ex31d1.htm EX-31.1 10170
8 EX-31.2 a15-1897_1ex31d2.htm EX-31.2 10032
9 EX-32.1 a15-1897_1ex32d1.htm EX-32.1 5029
10 EX-32.2 a15-1897_1ex32d2.htm EX-32.2 5025
17 GRAPHIC g18971boi001.jpg GRAPHIC 33159
  Complete submission text file 0001104659-15-020147.txt   9700297

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT sgyp-20141231.xml EX-101.INS 1332318
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20141231.xsd EX-101.SCH 68042
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20141231_cal.xml EX-101.CAL 58172
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20141231_def.xml EX-101.DEF 263043
15 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgyp-20141231_lab.xml EX-101.LAB 564569
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20141231_pre.xml EX-101.PRE 425203
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35268 | Film No.: 15704099
SIC: 2834 Pharmaceutical Preparations